Showing 26–34 of 34 · Medical devices & monitoring
FY2025 revenue SEK 1.34bn (+12.8%); operating margin 21.7%; net income SEK 228.0m.
Balance sheet figures not captured from release.
FY2026 revenue $5.65bn (+9.9%); operating margin 33.4%; net income $1.52bn.
Cash $1.47bn; debt $659.4m.
FY2025 revenue $6.16bn (+6.1%); operating margin 12.9%; net income $625.0m.
Net debt $2.76bn including leases.
FY2025 revenue $25.12bn (+11.2%); operating margin 19.5%; net income $3.25bn.
Balance sheet figures not captured from release.
Listed (4543.T).
Latest full-year results not yet captured by HSH.
Parent Siemens Healthineers (SHL.DE) group FY2026 revenue €23.60bn; adjusted EBIT margin 16.2%.
Comparable revenue growth 4.0%; adjusted EBIT about €3.8bn. Net income not captured.
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Listed (002223.SZ).
Latest full-year results not yet captured by HSH.
FY2025 revenue $8.23bn (+7.2%); operating margin 13.3%; net income $705.1m.
Cash $591.9m; debt $7.52bn.